Philly Jury Urged To Find Takeda Cancer Warnings Fell Short
A Philadelphia jury was urged during closing arguments Thursday to find that Takeda Pharmaceutical Co. Ltd. had failed to provide adequate warnings to a plaintiff's physician about the risk of bladder...To view the full article, register now.
Already a subscriber? Click here to view full article